Site of action of torasemide in man

  • R. Cuvelier
  • P. Pellegrin
  • M. Lesne
  • Ch. van Ypersele de Strihou
Article

Summary

The effect of torasemide, a new orally and parenterally active diuretic agent, on the renal mechanisms of dilution and concentration was studied in 6 healthy volunteers. The experimental conditions included water and osmotic diuresis. Torasemide caused maximal chloruresis and natriuresis during the 20–40 min after administration. The effect was more pronounced under osmotic diuresis and persisted throughout the 100 min of those experiments. A distinct effect both on free water clearance (\(CL_{H_2 0}\)) during water diuresis and tubular reabsorption of solute free water (\(T_{cH_2 0}\)) during osmotic diuresis strongly suggests that the major site of action of torasemide is the ascending limb of the loop of Henle. Comparison with furosemide under osmotic diuresis indicates longer abolition of \(T_{cH_2 0}\)/GFR by torasemide in keeping with the fact that its half-life is 2- to 3-times longer than that of furosemide.

Key words

torasemide diuretics renal tube pharmacodynamics site of action 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brater DC (1979) Renal sites of action of azosemide. Clin Pharmacol Ther 25: 428–434Google Scholar
  2. Buchborn E, Anastasakis S (1964) Angriffspunkt und Wirkungsmechanismus von Furosemid am distalen Nephron des Menschen. Klin Wochenschr 42: 1127–1131Google Scholar
  3. Counihan TB, Evans BM, Milne MD (1954) Observations on the pharmacology of the carbonic anhydrase inhibitor “Diamox”. Clin Sci 13: 583Google Scholar
  4. Delarge J, Lapiere C (1974) Synthèse et propriétés pharmacologiques de quelques N-acylsulfonamides. Ann Pharm Franç 32: 657Google Scholar
  5. Delarge J, Lapiere C (1978) Une nouvelle classe de diurétiques “high ceiling”, dérivés de l'alkyl-l((phénylamino-4-pyridul-3)sulfonyl)-3 urée. Ann Pharm Franç 36: 369Google Scholar
  6. Goldberg M, McCurdy DK, Foltz EL, Bluemle LW Jr (1964) Effects of ethacrynic acid (a new saluretic agent) on renal diluting and concentrating mechanism: Evidence for site of action in the loop of Henle. J Clin Invest 43: 201–216Google Scholar
  7. Heinemann HO, Demartini FE, Laragh JG (1959) The effects of chlorothiazide on renal excretion of electrolytes and free water. Am J Med 26: 853Google Scholar
  8. Jayakumar S, Puschett JB (1977) Study of the sites and mechanisms of action of bumetanide in man. J Pharmacol Exp Ther 201: 251–258Google Scholar
  9. Lesne M, Clerckx-Braun F, Duhoux P, van Ypersele de Strihou C (1982) Pharmacokinetic study of torasemide in humans: An overview of its diuretic effect. Int J Clin Pharmacol Ther Toxicol 20: 382–387Google Scholar
  10. Morrin PAF (1966) The effect of furosemide, a new diuretic agent, on renal concentrating and diluting mechanisms. Can J Physiol Pharmacol 44: 129–137Google Scholar
  11. Saruta T, Kato E (1980) The diuretic effect of piretanide in man. Drug Res 30: 1807–1812Google Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • R. Cuvelier
    • 1
  • P. Pellegrin
    • 2
  • M. Lesne
    • 2
  • Ch. van Ypersele de Strihou
    • 1
  1. 1.Department of NephrologyCliniques Universitaires St-Luc, University of Louvain Medical SchoolBrusselsBelgium
  2. 2.Department of PharmacologyCliniques Universitaires St-Luc, University of Louvain Medical SchoolBrusselsBelgium

Personalised recommendations